+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vectura Group plc - logo

Vectura Pharma was established in 1997, and its headquarters are in Chippenham in the U.K. Vectura Group plc researches, develops, and commercializes novel therapeutic products and drug delivery systems for the treatment of airways-related diseases Vectura entered into its first global commercialisation and development agreement with Novartis for NVA237. The company’s marketed products include Ultibro Breezhaler and Seebri Breezhaler for the treatment of chronic obstructive pulmonary disease (COPD).

From
Pharmaceutical API Manufacturing Market Report 2025 - Product Thumbnail Image

Pharmaceutical API Manufacturing Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
From
From
Asthma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Asthma Therapeutics - Global Strategic Business Report

  • Report
  • April 2025
  • 194 Pages
  • Global
From
From
Asthma Drugs Market Report 2025 - Product Thumbnail Image

Asthma Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Loading Indicator